Ultragenyx Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
18.02.26
/
50%
€17.40
Target price
18.02.27
€66.69
Performance (%)
14.83%
Price
07.04.26
€19.80
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 14.83%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 16.154% | 16.154% |
| iShares Core DAX® | 0,23 % | -2,41 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % |
| iShares S&P 500 | 1,07 % | -1,58 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $128.00 to $79.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat